1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Mid-Size Pharmaceutical – By Type

1.3.2        North America Mid-Size Pharmaceutical – By Drug Development Type

1.3.3        North America Mid-Size Pharmaceutical – By Formulation

1.3.4        North America Mid-Size Pharmaceutical – By Therapy Area

1.3.5        North America Mid-Size Pharmaceutical – By Country

2.           Mid-Size Pharmaceutical– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Mid-Size Pharmaceutical – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert Opinion

5.           Mid-Size Pharmaceutical Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Chronic Disorders

5.1.2        Increasing Product Approval and Launches

5.2         Market Restraints

5.2.1        High Competition among Market Players

5.3         Market Opportunities

5.3.1        Rising Number of Healthcare Start-ups

5.4         Future Trends

5.4.1        Increasing Focus on R&D

5.5         Impact Analysis

6.           Mid-Size Pharmaceutical Market– North America Analysis

6.1         North America Mid-Size Pharmaceutical Market Revenue Forecast and Analysis

7.           North America Mid-Size Pharmaceutical Market Revenue and Forecasts To 2028– by Type

7.1         Overview

7.2         North America Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)

7.3         Prescription

7.3.1        Overview

7.3.2        Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Over-the-Counter (OTC)

7.4.1        Overview

7.4.2        Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Mid-Size Pharmaceutical Market Analysis – By Drug Development Type

8.1         Overview

8.2         North America Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)

8.3         In-House

8.3.1        Overview

8.3.2        In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Outsource

8.4.1        Overview

8.4.2        Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Mid-Size Pharmaceutical Market – By Formulation

9.1         Overview

9.2         North America Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)

9.3         Tablets and Capsules

9.3.1        Overview

9.3.2        Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Injectables

9.4.1        Overview

9.4.2        Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Sprays

9.5.1        Overview

9.5.2        Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Other Formulations

9.6.1        Overview

9.6.2        Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Mid-Size Pharmaceutical Market – By Therapy Class

10.1      Overview

10.2      North America Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)

10.3      Cardiovascular Diseases

10.3.1     Overview

10.3.2     Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Pain Management

10.4.1     Overview

10.4.2     Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Diabetes

10.5.1     Overview

10.5.2     Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Cancer

10.6.1     Overview

10.6.2     Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.7      Other Diseases

10.7.1     Overview

10.7.2     Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.        North America Mid-Size Pharmaceutical Market Revenue and Forecasts to 2028 – Country Analysis

11.1      Overview

11.1.2     North America: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)

11.1.2.1       US: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.1.1       Overview

11.1.2.1.2       US: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.1.3       US: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million)

11.1.2.1.4       US: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million)

11.1.2.1.5       US: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million)

11.1.2.1.6       US: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million)

11.1.2.2       Canada: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.2.1       Overview

11.1.2.2.2       Canada: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.2.3       Canada: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million)

11.1.2.2.4       Canada: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million)

11.1.2.2.5       Canada: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million)

11.1.2.2.6       Canada: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million)

11.1.2.3       Mexico: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.3.1       Overview

11.1.2.3.2       Mexico: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

11.1.2.3.3       Mexico: Mid-Size Pharmaceutical Market, by Type, 2019–2028 (US$ Million)

11.1.2.3.4       Mexico: Mid-Size Pharmaceutical Market, by Drug Development Type, 2019–2028 (US$ Million)

11.1.2.3.5       Mexico: Mid-Size Pharmaceutical Market, by Formulation, 2019–2028 (US$ Million)

11.1.2.3.6       Mexico: Mid-Size Pharmaceutical Market, by Therapy Area, 2019–2028 (US$ Million)

12.        Mid-Size Pharmaceutical Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market, (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      DAIICHI SANKYO COMPANY LIMITED

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Eisai Co., Ltd.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bausch Health Companies Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Regeneron Pharmaceuticals, Inc

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Sun Pharmaceutical Industries Ltd

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Alexion Pharmaceuticals, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Mallinckrodt

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Endo Pharmaceuticals Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Canada: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Mexico: Mid-Size Pharmaceutical Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico Mid-Size Pharmaceutical Market, by Drug Development Type– Revenue and Forecast to 2028 (US$ Million)

Table 11.          Mexico Mid-Size Pharmaceutical Market, by Formulation – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Mexico Mid-Size Pharmaceutical Market, by Therapy Area – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Organic Developments Done By Companies

Table 14.          Inorganic Developments Done By Companies

Table 15.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Mid-Size Pharmaceutical Segmentation

Figure 2.           North America Mid-Size Pharmaceutical Segmentation, By Country

Figure 3.           North America Mid-Size Pharmaceutical Overview

Figure 4.           Over-the-Counter Segment Held Largest Share by Type in North America Mid-Size Pharmaceutical Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           North America Mid-Size Pharmaceutical Market– Revenue Forecast And Analysis – 2020- 2028

Figure 8.           North America Mid-Size Pharmaceutical Market Revenue Share, by Type (2022 and 2028)

Figure 9.           North America Prescription: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.        North America Over-the-Counter: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        North America Mid-Size Pharmaceutical Market Revenue Share, by Drug Development Type (2022 and 2028)

Figure 12.        North America In-House: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        North America Outsource: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Mid-Size Pharmaceutical Market, by Formulation, 2022 and 2028 (%)

Figure 15.        North America Tablets and Capsules: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        North America Injectables: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        North America Sprays: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        North America Others: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        North America Mid-Size Pharmaceutical Market, by Therapy Class, 2022 and 2028 (%)

Figure 20.        North America Cardiovascular Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        North America Pain Management: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        North America Diabetes: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        North America Cancer: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        North America Other Diseases: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        North America: Mid-Size Pharmaceutical Market, by Key Country – Revenue (2022) (US$ Million)

Figure 26.        North America: Mid-Size Pharmaceutical Market, by Country, 2021 & 2028 (%)

Figure 27.        US: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Canada: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Mexico: Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Growth Strategies Done by the Companies in the Market, (%)